Yano, Seiji <br/><br/>
Antitumor vascular strategy for controlling experimental metastatic spread of human small-cell lung cancer cells with ZD6474 in natural killer cell-depleted severe combined immunodeficient mice.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Dec 2005 
 - 8789-98 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-05-0674  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--pharmacology<br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Small Cell--drug therapy<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Endothelium, Vascular--drug effects<br/>Humans<br/>Killer Cells, Natural--immunology<br/>Lung Neoplasms--drug therapy<br/>Lymphocyte Depletion<br/>Mice<br/>Mice, SCID<br/>Neovascularization, Pathologic--drug therapy<br/>Piperidines--pharmacology<br/>Quinazolines--pharmacology<br/>RNA, Messenger--analysis<br/>Vascular Endothelial Growth Factor A--analysis<br/>Vascular Endothelial Growth Factor Receptor-1--analysis<br/>Vascular Endothelial Growth Factor Receptor-2--analysis<br/>Vascular Endothelial Growth Factor Receptor-3--analysis<br/>Xenograft Model Antitumor Assays